Can you remind me when keytruda was approved by the fda for cancer treatment?

When did the FDA approve Keytruda (pembrolizumab) for cancer?

The FDA’s first approval of Keytruda (pembrolizumab) was on September 4, 2014 for the treatment of unresectable or metastatic melanoma in patients who had progressed after prior therapy and, depending on mutation status, had no satisfactory alternative treatment options. [1]

Did Keytruda get approval for other cancers later?

Yes. Keytruda has received multiple FDA approvals across different cancer types over time, expanding well beyond melanoma as new trial results and indications were reviewed and authorized. [2]

What’s the fastest way to check the exact approval date for the indication you mean?

If you tell me which cancer type or indication you’re thinking of (for example, lung cancer, head and neck cancer, lymphoma, or triple-negative breast cancer), I can narrow the answer to the relevant FDA approval entry.

Sources:
[1] https://www.drugs.com/history/keytruda.html
[2] https://www.drugs.com/history/pembrolizumab.html